ES2209530T3 - Procedimiento para la preparacion de cicleno. - Google Patents
Procedimiento para la preparacion de cicleno.Info
- Publication number
- ES2209530T3 ES2209530T3 ES99959326T ES99959326T ES2209530T3 ES 2209530 T3 ES2209530 T3 ES 2209530T3 ES 99959326 T ES99959326 T ES 99959326T ES 99959326 T ES99959326 T ES 99959326T ES 2209530 T3 ES2209530 T3 ES 2209530T3
- Authority
- ES
- Spain
- Prior art keywords
- hours
- reaction
- solvent
- ethane
- carbonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims description 10
- QBPPRVHXOZRESW-UHFFFAOYSA-N 1,4,7,10-tetraazacyclododecane Chemical compound C1CNCCNCCNCCN1 QBPPRVHXOZRESW-UHFFFAOYSA-N 0.000 title description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 67
- 238000006243 chemical reaction Methods 0.000 claims description 46
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 39
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 33
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 28
- 239000002904 solvent Substances 0.000 claims description 24
- 238000001704 evaporation Methods 0.000 claims description 23
- 230000008020 evaporation Effects 0.000 claims description 23
- 238000010992 reflux Methods 0.000 claims description 22
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 claims description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 229940015043 glyoxal Drugs 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 102000016736 Cyclin Human genes 0.000 claims description 13
- 108050006400 Cyclin Proteins 0.000 claims description 13
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 13
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- 239000002168 alkylating agent Substances 0.000 claims description 5
- 229940100198 alkylating agent Drugs 0.000 claims description 5
- 239000003586 protic polar solvent Substances 0.000 claims description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- GBBZLMLLFVFKJM-UHFFFAOYSA-N 1,2-diiodoethane Chemical compound ICCI GBBZLMLLFVFKJM-UHFFFAOYSA-N 0.000 claims description 3
- 239000007859 condensation product Substances 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- 239000001095 magnesium carbonate Substances 0.000 claims description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 3
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 claims description 2
- QJNULWKDWXIXLJ-UHFFFAOYSA-N 1,2-bis(methylsulfonyl)ethane Chemical compound CS(=O)(=O)CCS(C)(=O)=O QJNULWKDWXIXLJ-UHFFFAOYSA-N 0.000 claims description 2
- ATPZFDFVYMLXFX-UHFFFAOYSA-N 1-methyl-4-[2-(4-methylphenyl)sulfonylethylsulfonyl]benzene Chemical compound C1=CC(C)=CC=C1S(=O)(=O)CCS(=O)(=O)C1=CC=C(C)C=C1 ATPZFDFVYMLXFX-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 2
- 239000000920 calcium hydroxide Substances 0.000 claims description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 2
- KLKFAASOGCDTDT-UHFFFAOYSA-N ethoxymethoxyethane Chemical compound CCOCOCC KLKFAASOGCDTDT-UHFFFAOYSA-N 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 claims description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 claims description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 2
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 235000011181 potassium carbonates Nutrition 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 229940086066 potassium hydrogencarbonate Drugs 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 238000006482 condensation reaction Methods 0.000 claims 2
- 239000003880 polar aprotic solvent Substances 0.000 claims 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- QWDJLDTYWNBUKE-UHFFFAOYSA-L magnesium bicarbonate Chemical compound [Mg+2].OC([O-])=O.OC([O-])=O QWDJLDTYWNBUKE-UHFFFAOYSA-L 0.000 claims 1
- 239000002370 magnesium bicarbonate Substances 0.000 claims 1
- 229910000022 magnesium bicarbonate Inorganic materials 0.000 claims 1
- 235000014824 magnesium bicarbonate Nutrition 0.000 claims 1
- 230000000269 nucleophilic effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 235000015424 sodium Nutrition 0.000 claims 1
- 125000003698 tetramethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 238000005580 one pot reaction Methods 0.000 abstract 1
- RRBYUSWBLVXTQN-UHFFFAOYSA-N tricyclene Chemical compound C12CC3CC2C1(C)C3(C)C RRBYUSWBLVXTQN-UHFFFAOYSA-N 0.000 abstract 1
- RRBYUSWBLVXTQN-VZCHMASFSA-N tricyclene Natural products C([C@@H]12)C3C[C@H]1C2(C)C3(C)C RRBYUSWBLVXTQN-VZCHMASFSA-N 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 53
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 20
- 238000003756 stirring Methods 0.000 description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 239000011343 solid material Substances 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- DHKHKXVYLBGOIT-UHFFFAOYSA-N 1,1-Diethoxyethane Chemical compound CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 9
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 9
- 238000005292 vacuum distillation Methods 0.000 description 9
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 3
- CASDNPHWJOQUQX-UHFFFAOYSA-N 1-benzylaziridine Chemical compound C=1C=CC=CC=1CN1CC1 CASDNPHWJOQUQX-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010959 commercial synthesis reaction Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- OAEGRYMCJYIXQT-UHFFFAOYSA-N dithiooxamide Chemical compound NC(=S)C(N)=S OAEGRYMCJYIXQT-UHFFFAOYSA-N 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- RYHQMKVRYNEBNJ-BMWGJIJESA-K gadoterate meglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 RYHQMKVRYNEBNJ-BMWGJIJESA-K 0.000 description 1
- DPNNNPAKRZOSMO-UHFFFAOYSA-K gadoteridol Chemical compound [Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 DPNNNPAKRZOSMO-UHFFFAOYSA-K 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- RTWNYYOXLSILQN-UHFFFAOYSA-N methanediamine Chemical compound NCN RTWNYYOXLSILQN-UHFFFAOYSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- XPDWGBQVDMORPB-UHFFFAOYSA-N trifluoromethane acid Natural products FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steering Devices For Bicycles And Motorcycles (AREA)
- Tyre Moulding (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19856481 | 1998-12-02 | ||
| DE19856481A DE19856481C1 (de) | 1998-12-02 | 1998-12-02 | Verfahren zur Herstellung von Cyclen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2209530T3 true ES2209530T3 (es) | 2004-06-16 |
Family
ID=7890308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99959326T Expired - Lifetime ES2209530T3 (es) | 1998-12-02 | 1999-11-17 | Procedimiento para la preparacion de cicleno. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1135376B1 (cs) |
| JP (1) | JP4636690B2 (cs) |
| KR (1) | KR100639270B1 (cs) |
| CN (1) | CN1155583C (cs) |
| AT (1) | ATE250042T1 (cs) |
| AU (1) | AU764260B2 (cs) |
| CA (1) | CA2353680C (cs) |
| CZ (1) | CZ300157B6 (cs) |
| DE (2) | DE19856481C1 (cs) |
| DK (1) | DK1135376T3 (cs) |
| ES (1) | ES2209530T3 (cs) |
| HK (1) | HK1044148B (cs) |
| IL (1) | IL143079A (cs) |
| NO (1) | NO318054B1 (cs) |
| NZ (1) | NZ512051A (cs) |
| PT (1) | PT1135376E (cs) |
| SK (1) | SK285372B6 (cs) |
| WO (1) | WO2000032581A1 (cs) |
| ZA (1) | ZA200105406B (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2830253B1 (fr) * | 2001-09-28 | 2005-02-04 | Air Liquide | Nouveau procede de preparation de macrocycles azotes c-fonctionnalises et nouveaux intermediaires obtenus |
| CN103360333B (zh) * | 2013-07-22 | 2016-03-30 | 厦门市华兴化工有限公司 | 一种高纯度轮环藤宁的制备方法 |
| CN106490298B (zh) * | 2016-11-28 | 2020-05-22 | 华南理工大学 | 一种高分散性植物蛋白及其制备方法 |
| US10344115B2 (en) | 2017-05-25 | 2019-07-09 | International Business Machines Corporation | Amine glyoxal resins |
| KR20190108383A (ko) | 2018-03-14 | 2019-09-24 | 주식회사 지에이치바이오텍 | 옥사미드 및 수소화알루미늄리튬을 이용한 시클렌의 신규 합성법 |
| EP4067348A1 (en) | 2021-03-30 | 2022-10-05 | Bracco Imaging SPA | Process for the preparation of cyclen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9504922D0 (en) * | 1995-03-10 | 1995-04-26 | Nycomed As | Process |
| IT1284046B1 (it) * | 1996-06-21 | 1998-05-08 | Bracco Spa | Processo per la preparazione di tetraazamacrocicli |
| IT1290457B1 (it) * | 1997-04-04 | 1998-12-03 | Bracco Spa | Processo per la preparazione di tetraazamacrocicli |
| IT1291673B1 (it) * | 1997-04-28 | 1999-01-19 | Bracco Spa | Processo per la preparazione di 1,4,7,10 - tetraazaciclododecano |
-
1998
- 1998-12-02 DE DE19856481A patent/DE19856481C1/de not_active Expired - Lifetime
-
1999
- 1999-11-17 DE DE59907056T patent/DE59907056D1/de not_active Expired - Lifetime
- 1999-11-17 NZ NZ512051A patent/NZ512051A/en not_active IP Right Cessation
- 1999-11-17 ES ES99959326T patent/ES2209530T3/es not_active Expired - Lifetime
- 1999-11-17 KR KR1020017006832A patent/KR100639270B1/ko not_active Expired - Fee Related
- 1999-11-17 AU AU16543/00A patent/AU764260B2/en not_active Ceased
- 1999-11-17 EP EP99959326A patent/EP1135376B1/de not_active Expired - Lifetime
- 1999-11-17 HK HK02104835.9A patent/HK1044148B/zh not_active IP Right Cessation
- 1999-11-17 WO PCT/EP1999/009089 patent/WO2000032581A1/de active IP Right Grant
- 1999-11-17 JP JP2000585223A patent/JP4636690B2/ja not_active Expired - Fee Related
- 1999-11-17 AT AT99959326T patent/ATE250042T1/de active
- 1999-11-17 SK SK724-2001A patent/SK285372B6/sk not_active IP Right Cessation
- 1999-11-17 IL IL14307999A patent/IL143079A/xx not_active IP Right Cessation
- 1999-11-17 CN CNB998140635A patent/CN1155583C/zh not_active Expired - Fee Related
- 1999-11-17 CZ CZ20011915A patent/CZ300157B6/cs not_active IP Right Cessation
- 1999-11-17 CA CA002353680A patent/CA2353680C/en not_active Expired - Fee Related
- 1999-11-17 DK DK99959326T patent/DK1135376T3/da active
- 1999-11-17 PT PT99959326T patent/PT1135376E/pt unknown
-
2001
- 2001-06-01 NO NO20012703A patent/NO318054B1/no not_active IP Right Cessation
- 2001-06-29 ZA ZA200105406A patent/ZA200105406B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU764260B2 (en) | 2003-08-14 |
| EP1135376B1 (de) | 2003-09-17 |
| CZ20011915A3 (cs) | 2001-09-12 |
| CN1155583C (zh) | 2004-06-30 |
| NZ512051A (en) | 2003-10-31 |
| CA2353680C (en) | 2008-09-09 |
| NO20012703D0 (no) | 2001-06-01 |
| SK7242001A3 (en) | 2001-12-03 |
| ATE250042T1 (de) | 2003-10-15 |
| WO2000032581A1 (de) | 2000-06-08 |
| IL143079A0 (en) | 2002-04-21 |
| HK1044148B (zh) | 2005-04-01 |
| SK285372B6 (sk) | 2006-12-07 |
| CN1329603A (zh) | 2002-01-02 |
| KR100639270B1 (ko) | 2006-10-27 |
| PT1135376E (pt) | 2004-02-27 |
| DE19856481C1 (de) | 2000-07-06 |
| EP1135376A1 (de) | 2001-09-26 |
| KR20010080648A (ko) | 2001-08-22 |
| HK1044148A1 (en) | 2002-10-11 |
| NO20012703L (no) | 2001-06-01 |
| AU1654300A (en) | 2000-06-19 |
| ZA200105406B (en) | 2002-07-25 |
| JP4636690B2 (ja) | 2011-02-23 |
| DE59907056D1 (de) | 2003-10-23 |
| JP2003522114A (ja) | 2003-07-22 |
| CZ300157B6 (cs) | 2009-02-25 |
| IL143079A (en) | 2005-08-31 |
| CA2353680A1 (en) | 2000-06-08 |
| DK1135376T3 (da) | 2004-01-19 |
| NO318054B1 (no) | 2005-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100269081B1 (ko) | N-베타-히드록시알킬-트리-n-카르복시알킬-1,4,7,10-테트라아자시클로도데칸및n-베타-히드록시알킬-트리-n-카르복시알킬-1,4,8,11-테트라아자시클로테트라데칸유도체및그들의금속착화합물의제조방법 | |
| ES2209530T3 (es) | Procedimiento para la preparacion de cicleno. | |
| Gansow et al. | Synthesis and characterization of some bifunctional 2B: 2: 1 cryptands | |
| ES2325982T3 (es) | Compuestos complejos con litio de n-(1-hidroximetil-2,3-dihidroxipropil)-1,4,7-tris-carboximetil-1,4,7,10-tetraazaciclododecano, su preparacion y su utilizacion. | |
| ES2320323T3 (es) | Procedimiento para la preparacion de poliamidas ciclicas con proteccion n-1 que contienen atomos de nitrogeno en forma de anillo n, y producto asi obtenido. | |
| ES2218711T3 (es) | Procedimiento para la preparacion de amidas de acidos carboxilicos complejos con metales. | |
| ES2215130T3 (es) | Proceso para la sintesis de un derivado conocido de tetrazol. | |
| CN118994300A (zh) | 一种蛋白降解靶向嵌合体及其应用 | |
| CN108640884A (zh) | 2-吗啉酮盐及其制备方法、2-吗啉酮的制备方法 | |
| JP2006527241A (ja) | シス−８ｂ−メチルデカヒドロ−２ａ，４ａ，６ａ，８ａ−テトラアザシクロペンタ［ｆｇ］アセナフチレン、シス−デカヒドロ−２ａ，４ａ，６ａ，８ａ−テトラアザシクロペンタ［ｆｇ］アセナフチレン、サイクレンおよび官能化サイクレン | |
| US6156890A (en) | Process for the production of cyclene | |
| CN111138335B (zh) | 一种光学活性2-甲基脯氨酸的制备方法 | |
| ES2291099A1 (es) | Mejoras en el objeto de la patente principal num. 200500485, por "procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis". | |
| ES2984183T3 (es) | Proceso para preparar derivados de anfetamina acilados | |
| ES2223841T3 (es) | Procedimiento para la preparacion de dinitrodiazaalcanos y productos intermedios para ellos. | |
| ES2314366T3 (es) | Procedimiento para la fabricacion de alcaloides de quinazolina. | |
| ES2298998T3 (es) | Sistesis de espongosina. | |
| ES2261508T3 (es) | Procedimiento para la produccion de sal de disodio del acido fenilen-bis-bencimidazol-tetrasulfonico. | |
| ES2232805T3 (es) | Pirazolopiridinonas como intermediarios. | |
| Einberg | Acylation of 5-aminotetrazoles | |
| Zhang et al. | Fuxian Wan, Mingjie Liu, Junzheng | |
| SU919313A1 (ru) | Способ получени 5 @ - @ -триазоло (5,1- @ ) изоиндола | |
| CN119930540A (zh) | 一种多替诺雷的制备方法 | |
| Sato et al. | A Study on the Synthesis of Calix [4 and 6] arenes Using Alternately Arranged Phloroglucinols and p-tert-Butylphenols | |
| Devi et al. | Synthesis of pendant polyaminopolycarboxylic acid crown ethers: potential ligands for MRI contrasting agents |